Toponostics of invasive ductal breast carcinoma: Combination of spatial protein expression imaging and quantitative proteome signature analysis

International Journal of Clinical and Experimental Pathology

Volumn 4, Issue 5, 2011, Pages 454-467

  Röwer, Claudia ^a   Ziems, Björn ^a,b   Radtke, Anngret ^c   Schmitt, Oliver ^a   Reimer, Toralf ^a   Koy, Cornelia ^a   Thiesen, Hans Jürgen ^a,b   Gerber, Bernd ^a   Glocker, Michael O ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b IndyMed GmbH   (Germany)

^c University Südstadt Klinik Rostock   (Germany)

Author keywords

Breast carcinoma; Im; Mass spectrometry; Protein expression signature; Proteome analysis; Proteomics

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NUCLEAR PROTEIN; NUCLEOPHOSMIN; NUCLEOSIDE DIPHOSPHATE KINASE; OGN PROTEIN, HUMAN; PARAFFIN; PYRUVATE KINASE; SIGNAL PEPTIDE; TUMOR MARKER;

ADULT; AGED; ALGORITHM; ARTICLE; BREAST; BREAST TUMOR; FEMALE; HUMAN; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROTEOMICS;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; NUCLEAR PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; PARAFFIN EMBEDDING; PROTEOMICS; PYRUVATE KINASE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 80054783324     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Decaestecker C, Moles Lopez X, D́Haene N, Roland I, Guendouz S, Duponchelle C, Alix B, Debeir O and Salmon I. Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis. Proteomics 2009; 9: 4478-4494.
2. Pontén F, Jirström K and Uhlen M. The Human Protein Atlas-a tool for pathology. J Pathol 2008; 216: 387-393.
3. Warford A, Howat W and McCafferty J. Expression profiling by high-throughput immunohistochemistry. J Immunol Methods 2004; 290: 81-92.
4. Taylor CR and Levenson RM. Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment II. Histopathology 2006; 49: 411-424.
5. Nakhleh RE. Error Reduction in Surgical Pathology. Arch. Pathol. Lab. Med. 2006; 130: 630-632.
6. Takikita M, Chung J-Y and Hewitt SM. Tissue microarrays enabling high-throughput molecular pathology. Curr Opin Biotechnol 2007; 18: 318-325.
7. Tuominen VJ, Ruotoistenmäki S, Viitanen A, Jumppanen M and Isola J. ImmunoRation: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 2010; 12: R56.
8. Rojo MG, Bueno G and Slodkowska J. Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice. Folia Histochem Cytobiol 2009; 47: 349-354.
9. Strömberg S, Björklund MG, Asplund C, Sköllermo A, Persson A, Wester K, Kampf C, Nilsson P, Andersson A-C, Uhlen M, Kononen J, Pontén F and Asplund A. A high-throughput strategy for protein profiling in cell microarrays using automated image analysis. Proteomics 2007; 7: 2142-2150.
10. Gloriam DE, Orchard S, Bertinetti D, Björling E, Bongcam-Rudloff E, Borrebaeck CAK, Bourbeillon J, Bradbury ARM, de Daruvar A, Dübel S, Frank R, Gibson TJ, Gold L, Haslam N, Herberg FW, Hiltke T, Hoheisel JD, Kerrien S, Koegl M, Konthur Z, Korn B, Landegren U, Montecchi-Palazzi L, Palcy S, Rodriguez H, Schweinsberg S, Sievert V, Stoevesandt O, Taussig MJ, Ueffing M, Uhlén M, van der Maarel S, Wingren C, Woollard P, Sherman DJ and Hermjakob H. A Community Standard Format for the Representation of Protein Affinity Reagents. Mol Cell Proteomics 2009; 9: 1-10.
11. Röwer C, Koy C, Hecker M, Reimer T, Gerber B, Thiesen H-J and Glocker MO. Mass Spectrometric Characterization of Protein Structure Details Refines the Proteome Signature for Invasive Ductal Breast Carcinoma. J Am Soc Mass Spec
12. Röwer C, Vissers JPC, Koy C, Kipping M, Hecker M, Reimer T, Gerber B, Thiesen H-J and Glocker MO. Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue. Anal Bioanal Chem 2009; 395: 2443-2456.
13. Uhlen M, Björling E, Agaton C, Al-Khalili Szigyarto C, Amini B, Andersen E, Andersson A-C, Angelidou P, Asplund A, Asplund C, Berglund L, Bergström K, Brumer H, Cerjan D, Ekström M, Elobeid A, Eriksson C, Fagerberg L, Falk R, Fall J, Forsberg M, Björklund MG, Gumbel K, Halimi A, Hallin I, Hamsten C, Hansson M, Hedhammar M, Hercules G, Kampf C, Larsson K, Lindskog M, Lodewyckx W, Lund J, Lundeberg J, Magnusson K, Malm E, Nilsson P, Ödling J, Oksvold P, Olsson I, Öster E, Ottosson J, Paavilainen L, Persson A, Rimini R, Rockberg J, Runeson M, Sivertsson A, Sköllermo A, Steen J, Stenvall M, Sterky F, Strömberg S, Sundberg M, Tegel H, Tourle S, Wahlund E, Waldén A, Wan J, Wernérus H, Westberg J, Wester K, Wrethagen U, Xu LL, Hober S and Pontén F. A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics. Mol Cell Proteomics 2005; 4: 1920-1932.
14. Tukey JW. Exploratory Data Analysis. Addison Wesley, 1977.
15. Welch BL. The generalization of "Student́s" problem when several different population variances are involved. Biometrika 1947; 34: 28-35.
16. Elston CW. Classification and grading of invasive breast carcinoma. Verh. Dtsch Ges Pathol 2005; 89: 35-44.
17. Remmele W and Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987; 8: 138-140.
18. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M and Perou CM. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma. Clin Cancer Res 2004; 10: 5367-5374.
19. Ring BZ, Seitz RS, Beck R, Shasteen WJ, Tarr SM, Cheang MCU, Yoder BJ, Budd GT, Nielsen TO, Hicks DG, Estopinal NC and Ross DT. Novel Prognostic Immunohistochemical Biomarker Panel for Estrogen Receptor-Positive Breast Cancer. J Clin Oncol 2006; 24: 3039-3047.
20. Crabb SJ, Bajdik CD, Leung S, Speers CH, Kennecke H, Huntsmann DG and Gelmon KA. Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study. Breast Cancer Res 2008; 10: R6.
21. Schubert W. Topological proteomics, toponomics, MELK-technology. Adv Biochem Eng Biotechnol 2003; 83: 189-209.
22. Glocker MO, Guthke R, Kekow J and Thiesen H-J. Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine. Med Res Rev 2006; 26: 63-87.
23. Suckau D, Köhl J, Karwath G, Schneider K, Casaretto M, Bitter-Suermann D and Przybylski M. Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping. Proc Natl Acad Sci USA 1990; 87: 9848-9852.
24. Parker CE and Tomer KB. MALDI/MS-based epitope mapping of antigens bound to immobilized antibodies. Mol Biotechnol 2002; 20: 49-62.
25. El-Kased RF, Koy C, Lorenz P, Montgomery H, Tanaka K, Thiesen H-J and Glocker MO. A Novel Mass Spectrometric Epitope Mapping Approach without Immobilization of the Antibody. J Proteomics Bioinform 2011; 4: 1-9.
26. Leong AS. Quantitation in immunohistology: fact or fiction? A discussion of variables that influence results. Appl. Immunohistochem. Mol Morphol 2004; 12: 1-7.
27. Apfeldorfer C, Ulrich K, Jones G, Goodwin D, Collins S, Schenck E and Richard V. Object orientated automated image analysis: quantitative and qualitative estimation of inflammation in mouse lung. Diagn Pathol 2008; 3 Suppl1: S16.
28. Paavilainen L, Edvinsson A, Asplund A, Hober S, Kampf C, Pontén F and Wester K. The Impact of Tissue Fixatives on Morphology and Antibodybased Protein Profiling in Tissues and Cells. J Histochem Cytochem 2010; 58: 237-246.
29. Hewitt SM, Takikita M, Abedi-Ardekani B, Kris Y, Bexfield K, Braunschweig T and Chung J-Y. Validation of proteomic-based discovery with tissue microarrays. Proteomics Clin Appl 2008; 2: 1460-1466.
30. Zieba A, Wählby C, Hjelm F, Jordan L, Berg J, Landegren U and Pardali K. Bright-Field Microscopy Visualization of Proteins and Protein Complexes by In Situ Proximity Ligation with Peroxidase Detection. Clin Chem 2010; 56: 99-110.
31. Pierre S and Scholich K. Toponomics: studying protein-protein interactions and protein networks in intact tissue. Mol Biosyst 2010; 6: 641-647.
32. Schwamborn K and Caprioli RM. Molecular imaging by mass spectrometry-looking beyond classical histology. Nat Rev Cancer 2010; 10: 639-646.
33. McDonnell LA, Corthals GL, Willems SM, van Remoortere A, van Zeijl RJM and Deelder AM. Peptide and protein imaging mass spectrometry in cancer research. J Proteomics 2010; 73: 1921-1944.